These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 793994)
21. Lethal and adjuvant activities of cord factor (trehalose-6,6'-dimycolate) and synthetic analogs in mice. Numata F; Nishimura K; Ishida H; Ukei S; Tone Y; Ishihara C; Saiki I; Sekikawa I; Azuma I Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4544-55. PubMed ID: 3004751 [No Abstract] [Full Text] [Related]
22. Role of cord factor (trehalose-6,6'-dimycolate) in allergic granuloma formation in rabbits. Moore VL; Myrvik QN; Kato M Infect Immun; 1972 Jul; 6(1):5-8. PubMed ID: 4564153 [TBL] [Abstract][Full Text] [Related]
23. Effects of BCG infection on the susceptibility of mouse macrophages to endotoxin. Peavy DL; Baughn RE; Musher DM; Musher DM Infect Immun; 1979 Apr; 24(1):59-64. PubMed ID: 378847 [TBL] [Abstract][Full Text] [Related]
24. Mycolyl glycolipids stimulate macrophages to release a chemotactic factor. Matsunaga I; Oka S; Inoue T; Yano I FEMS Microbiol Lett; 1990 Jan; 55(1-2):49-53. PubMed ID: 2328910 [TBL] [Abstract][Full Text] [Related]
25. No evidence for an interaction of the bacterial immunomodulator trehalose dimycolate (TDM) with liver drug-metabolizing system in mice. Zidek Z; Yanev S Immunopharmacol Immunotoxicol; 1987; 9(4):421-8. PubMed ID: 3437104 [TBL] [Abstract][Full Text] [Related]
26. Proceedings: Relationships between chemical structure and biochemical activity of trehalose-6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis. Asselineau J; Kato M Jpn J Med Sci Biol; 1975 Feb; 28(1):94-7. PubMed ID: 808660 [No Abstract] [Full Text] [Related]
27. Induction of delayed-type sensitivity to Leishmania parasite in a case of leishmaniasis cutanea diffusa with BCG and cord-factor (Trehalose-6-6' dimycolate). Cohen HA Acta Derm Venereol; 1979; 59(6):547-9. PubMed ID: 94221 [TBL] [Abstract][Full Text] [Related]
28. Antitumor activity and hydrogen peroxide release by macrophages elicited by trehalose diesters. Lepoivre M; Tenu JP; Lemaire G; Petit JF J Immunol; 1982 Aug; 129(2):860-6. PubMed ID: 6806386 [TBL] [Abstract][Full Text] [Related]
29. Immunotherapy of an ascitic rat hepatoma with cord factor (trehalose-6, 6'-dimycolate) and synthetic analogues. Pimm MV; Baldwin RW; Polonsky J; Lederer E Int J Cancer; 1979 Dec; 24(6):780-5. PubMed ID: 544531 [TBL] [Abstract][Full Text] [Related]
30. Immunotherapy with nonviable microbial components. Ribi E; Milner KC; Granger DL; Kelly MT; Yamamoto K; Brehmer W; Parker R; Smith RF; Strain SM Ann N Y Acad Sci; 1976; 277(00):228-38. PubMed ID: 187099 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide). Ribi EE; Cantrell JL; Von Eschen KB; Schwartzman SM Cancer Res; 1979 Nov; 39(11):4756-9. PubMed ID: 115579 [TBL] [Abstract][Full Text] [Related]
32. Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets. Masihi KN; Lange W; Rohde-Schulz B Cancer Immunol Immunother; 1987; 24(1):19-24. PubMed ID: 3815418 [TBL] [Abstract][Full Text] [Related]
33. Proliferative responses of central and peripheral rat lymphocytes elicited by cord factor (trehalose 6,6'-dimycolate). Kierszenbaum F; Walz DR Infect Immun; 1981 Jul; 33(1):115-9. PubMed ID: 6973543 [TBL] [Abstract][Full Text] [Related]